Abstract
Objective
To investigate the effects of Salvia Miltiorrhiza Liguspyragine Hydrochloride and Glucose Injection (参芎葡萄糖注射液, SLGI) on the expression of platelet membrane receptors proteinase-activated receptor-1 (PAR1) and proteinase-activated receptor-4 (PAR4) in end-stage renal disease (ESRD) patients on chronic haemodialysis (HD).
Methods
Eighty-six ESRD patients on HD (treated group) were treated with SLGI, 7 days as one therapeutic course, for two successive courses. The previous therapies were unchanged. Flow cytometry was used to assess the expression of platelet PAR1 and PAR4 in the patients, and turbidity method was used to determine the platelet maximum aggregation rate (MAR). Meanwhile, renal function was measured. The final data were compared with those before treatment and with those in the normal control group (54 healthy subjects).
Results
Compared with the normal control group, the expressions of PAR1 and PAR4 and platelet MAR in ESRD patients on HD was significantly higher before treatment (P=0.001, P=0.006, and P=0.008); after treatment with SLGI, the above indices in patients were remarkably decreased (P=0.036 and P=0.046), except PAR4 (P=0.067), but still higher than those in the normal control group, however, it was not statistically significant.
Conclusions
(1) The overexpression of PAR1 and PAR4 might lead to increased platelet aggregation and this could be one of the reasons for the thrombotic events in ESRD patients on HD. (2) SLGI was able to down-regulate the expression of PAR1 in ESRD patients on HD, improve platelet function, and regulate platelet activation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb Hemost 2004;30:579–589.
Li Y, Shen L, Chen R, Lu FR, Li J, Liu JG. Levels of main platelet thrombin receptors in older chronic haemodialysis patients. Chin Med J 2010;123:2495–2496.
Moal V, Brunet P, Dou L, Morange S, Sampol J, Berland Y. Impaired expression of glycoproteins on resting and stimulated platelets in uraemic patients. Nephrol Dial Transplant 2003;18:1834–1841.
Wang HY, eds. Nephropathy. 2nd ed. Beijing: People’s Medical Publishing House; 1996:1385.
Rink TJ, Sage SO. Calcium signaling in human platelets. Annu Rev Physiol 1990;52:431–449.
Wyant TL, Smith PC, Brown B, Kantor AB. Whole blood microvolume laser scanning cytometry for monitoring resting and activated platelets. Platelets 2001;12:309–318.
Smith FB, Rumley A, Lee AJ, Leng GC, Fowkes FG, Lowe GD. Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants. Br J Haematol 1998;100:758–763.
Qin Y, Shen L, Lu FR, Shi W, Liu JG. Effect of Xiaoyu Zhixue Tablet on the expression of platelet membrane glycoprotein Ib/IX/V complex in patients with chronic renal failure. Chin J Integr Med 2008;14:83–87.
Di Minno G, Cerbone A, Usberti M, Cianciaruso B, Cortese A, Farace MJ, et al. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen. J Lab Clin Med 1986;108:246–252.
Gralnick HR, McKeown LP, Williams SB, Shafer BC, Pierce L. Plasma and platelet von Willebrand factor defects in uremia. Am J Med 1988;85:806–810.
Zwaginga JJ, MJ IJ, de Groot PG, Vos J, de Bos Kuil RL, Sixma JJ. Defects in platelet adhesion and aggregate formation in uremic bleeding disorder can be attributed to factors in plasma. Arterioscler Thromb 1991;11:733–744.
Benigni A, Livio M, Dodesini P, Schieppati A, Panigada M, Mecca G, et al. Inhibition of human platelet aggregation by parathyroid hormone. Is cyclic AMP implicated? Am J Nephrol 1985;5:243–247.
Kyrle PA, Stockenhuber F, Brenner B, Gossinger H, Korninger C, Pabinger I, et al. Evidence for an increased generation of prostacyclin in the microvasculature and an impairment of the platelet alpha-granule release in chronic renal failure. Thromb Haemost 1988;60:205–208.
Covic L, Gresser AL, Kuliopulos A. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry 2000;39:5458–5467.
Shapiro MJ, Weiss EJ, Faruqi TR, Coughlin SR. Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J Biol Chem 2000;275:25216–25221.
Diaz-Ricart M, Estebanell E, Cases A, Calls J, Lopez-Pedret J, Carretero M, et al. Abnormal platelet cytoskeletal assembly in hemodialyzed patients results in deficient tyrosine phosphorylation signaling. Kidney Int 2000;57:1905–1914.
Yang HX, Jiang HB. Clinical observation of combination of Danshen and Chuanxiongqin Injection and Astragali Injection in patients with stable angina pectoris. J Hunan Environ Biol Polytechnic (Chin) 2008;14(3):7–9.
Li S, Wan L. Experimental study on the preventive mechanism of Salviae Miltiorrhizae against atherosclerosis in rabbits models. J Huazhong Univ Sci Technol Med Sci 2004;24:233–235.
Wang Yan, Li Yan. Efficacy of Asparagine Hydrochloride and Glucose Injection on ischemic colitis. Chin J Gastroentero Hepatol (Chin) 2009;18: 646–648.
Che XW, Zhang Y, Wang H, Wang W. Effect of ligustrazine injection on levels of interleukin-4 and interferon-gamma in patients with bronchial asthma. Chin J Integr Med 2008;14:217–220.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National Natural Science Foundation of China (No. 30572441)
Rights and permissions
About this article
Cite this article
Li, Y., Shen, L., Chen, R. et al. Effects of salivae miltiorrhizae liguspyragine hydrochloride and glucose injection (参芎葡萄糖注射液) on the levels of main platelet thrombin receptors in chronic haemodialysis patients. Chin. J. Integr. Med. 17, 625–630 (2011). https://doi.org/10.1007/s11655-011-0826-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-011-0826-8